Avoro Capital Advisors LLC

Q3 2024 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2024
Date filed
11/14/2024
Form type
13F-HR
Num holdings
36
Total value ($000)
$6,858,151
Net value change ($000)
-650,249 (-8.7%)
New positions
0
Sold out positions
6
Turnover %
10.7%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/14/2024 Next filing: 2/14/2025 SEC filing

Snapshot: Change Analysis

Compared to Q2 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ASND 172,550 30.1%
ARGX 138,758 26.1%
UTHR 113,784 12.5%
KYMR 96,902 83.5%
PCVX 90,849 209.2%
RNAM 50,040 18.8%
VERA 34,563 22.2%
KRYS 30,527 6.8%
TRML 28,555 99.9%
SLNO 24,779 29.0%
Top Reduces (Value $000, Stocks/ETFs)
Cerevel Therapeutics Holdings, Inc. -308,292 -100.0%
XBI -281,375 -100.0%
BMRN -231,960 -61.8%
SRPT -154,837 -32.7%
MDGL -145,290 -25.2%
APLS -105,778 -24.8%
ALNY -97,200 -100.0%
ARWR -58,844 -25.5%
IOVA -54,020 -57.6%
VRCA -29,160 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 125 (0.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type